Jung Choi - Aug 1, 2021 Form 4/A - Amendment Insider Report for Global Blood Therapeutics, Inc. (GBT)

Role
Officer
Signature
/s/ Miguel Carrillo, as Attorney-in-Fact
Stock symbol
GBT
Transactions as of
Aug 1, 2021
Transactions value $
-$102,296
Form type
4/A - Amendment
Date filed
9/24/2021, 07:00 PM
Date Of Original Report
Aug 3, 2021
Previous filing
Jun 4, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Options Exercise +9.02K +5.09% 186K Aug 1, 2021 Direct F1
transaction GBT Common Stock Tax liability -$102K -3.74K -2.01% $27.33 182K Aug 1, 2021 Direct F2
holding GBT Common Stock 25K Aug 1, 2021 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Restricted Stock Units Options Exercise $0 -2.88K -50% $0.00 2.88K Aug 1, 2021 Common Stock 2.88K Direct F1, F3
transaction GBT Restricted Stock Units Options Exercise $0 -3.13K -25% $0.00 9.38K Aug 1, 2021 Common Stock 3.13K Direct F1, F4
transaction GBT Restricted Stock Units Options Exercise $0 -3.02K -16.67% $0.00 15.1K Aug 1, 2021 Common Stock 3.02K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2 Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 9,020 shares of Common Stock underlying the Reporting Person's RSUs.
F3 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
F4 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
F5 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Remarks:

Title: Chief Business and Strategy Officer This amended Form 4 is being filed solely to attach a Power of Attorney granted by the Reporting Person which was not previously attached. All other information in the original Form 4 remains the same. The original Form 4 was timely filed on August 3, 2021. Exhibit 24 - Power of Attorney